Search Query :
8JUC
Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-ube2t through fragment-based screening Deposition Author(s): Anantharajan, J. , Baburajendran, N.
Date: 2023-06-26 Method: X-RAY DIFFRACTION Resolution: 1.54 Å Organism(s): Homo Sapiens Sequences Data: 8JUC_A
8JVD
Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-ube2t through fragment-based screening Deposition Author(s): Anantharajan, J. , Baburajendran, N.
Date: 2023-06-28 Method: X-RAY DIFFRACTION Resolution: 1.696 Å Organism(s): Homo Sapiens Sequences Data: 8JVD_A
8JVE
Identification and characterization of inhibitors covalently modifying catalytic cysteine of ube2t and blocking ubiquitin transfer Deposition Author(s): Anantharajan, J. , Baburajendran, N.
Date: 2023-06-28 Method: X-RAY DIFFRACTION Resolution: 1.76 Å Organism(s): Homo Sapiens Sequences Data: 8JVE_A
8JVL
Identification and characterization of inhibitors covalently modifying catalytic cysteine of ube2t and blocking ubiquitin transfer Deposition Author(s): Anantharajan, J. , Baburajendran, N.
Date: 2023-06-28 Method: X-RAY DIFFRACTION Resolution: 2.06 Å Organism(s): Homo Sapiens Sequences Data: 8JVL_A
9KGJ
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.37 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGJ_A , 9KGJ_B , 9KGJ_C , 9KGJ_D
9KGN
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.89 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGN_B , 9KGN_A , 9KGN_C , 9KGN_D
9KGQ
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGQ_B , 9KGQ_A , 9KGQ_C , 9KGQ_D
9KGR
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.47 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGR_A , 9KGR_B , 9KGR_C , 9KGR_D
9KGS
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-09 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGS_B , 9KGS_A , 9KGS_C , 9KGS_D
9LYF
Structure-based discovery of novel non-covalent small molecule inhibitors of usp30 Deposition Author(s): Anantharajan, J. , Baburajendran, N.
Date: 2025-02-20 Method: X-RAY DIFFRACTION Resolution: 2.58 Å Organism(s): Homo Sapiens Sequences Data: 9LYF_A